Navigation Links
SuperNova Diagnostics® to Present at the Rodman & Renshaw Global Investment Conference
Date:9/6/2011

WASHINGTON, LONDON and HONG KONG, Sept. 6, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced that Neil J. Campbell, President and CEO, will be presenting at the Rodman & Renshaw Global Investment Conference on September 13, 2011 from 10:50 -11:15 am EDT in the Metropolitan West room of the Waldorf-Astoria in New York, NY.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefence/biosecurity.  A live webcast and 90 day archive of the presentation will be available at http://www.wsw.com/webcast/rrshq20/spdi.

"Point-of-care and point-of-use diagnostics represent a multi-billion dollar market with an annual growth rate of 20 percent, making it one of the most significant investing and technological opportunities over the next five to 10 years," said Mr. Campbell. "SuperNova is at the forefront of this revolution, having developed our AmpCrystal® platform to provide an array of diagnostic capabilities, from patient treatment to pathogen detection. We welcome the opportunity to showcase our vision and technology to the many investors and industry leaders at the Rodman & Renshaw Global Investment Conference."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Media Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando
(212) 827-0020
jrando@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
2. SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
3. Dilon Diagnostics® Partners With PenRad®
4. Thoratec Announces Presentations at Upcoming Investor Conferences
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
7. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
8. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
9. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
10. Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
11. Amgen to Present at the Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Attending college is ... those with type 1 diabetes, the journey can be ... schedules, assignments and campus activities, they also manage the ... top of that, many are living away from home ... (Foundation) Lilly Diabetes Tomorrow,s Leaders Scholarship with $100,000 ...
(Date:2/11/2016)... , Feb. 11, 2016 Brain Cancer ... new treatment method at West Cancer Center . ... electric fields to inhibit cancer cell replication causing death ... more than a decade to show a significant extension ... Multiforme (GBM) patients. Currently, West Cancer Center is the ...
(Date:2/11/2016)... 2016  AbbVie, a global biopharmaceutical company, announced ... to provide financial support for exceptional students living ... education goals. Fifteen scholars will be selected to ... The AbbVie Rheumatology Scholarship is currently accepting applications. ... corporate social responsibility, brand and communications, AbbVie. "By ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... 2016 , ... The president released a FY 2017 budget request on Tuesday ... of the cost burden to military beneficiaries. , MOAA’s president, retired Air Force ... as including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative ... gearing up for their simultaneous grand openings in March. All seven practices are ... you’re probably wondering, is reversing diabetes possible? According to this 2011 CNN article ...
(Date:2/11/2016)... ... 2016 , ... Thermi™, a world leader in thermistor-regulated energy ... promotions of Allison Kelly to executive vice president of the company’s new North ... North American capital sales, and Wendy Oseas to vice president of global marketing. ...
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, Inc. ... Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. and ... Intel on value-based health benefits program Connected Care, will discuss the challenges they ...
(Date:2/11/2016)... ... February 11, 2016 , ... The Commission for Case Manager ... of Commissioners. Individuals interested in volunteer board service are encouraged to apply. The ... settings and across allied health to contribute to its mission and vision. The ...
Breaking Medicine News(10 mins):